Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Ossium Health, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sanofi
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
City of Hope Medical Center
Children's Oncology Group
University of Nebraska
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
Universität des Saarlandes
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Montefiore Medical Center